Venetoclax and azacitidine in untreated patients with therapy-related acute myeloid leukemia, antecedent myelodysplastic syndromes or chronic myelomonocytic leukemia

被引：0

作者：

Vinod Pullarkat ^{[1
]}

Keith W. Pratz ^{[2
]}

Hartmut Döhner ^{[3
]}

Christian Recher ^{[4
]}

Michael J. Thirman ^{[5
]}

Courtney D. DiNardo ^{[6
]}

Pierre Fenaux ^{[7
]}

Andre C. Schuh ^{[8
]}

Andrew H. Wei ^{[9
]}

Arnaud Pigneux ^{[10
]}

Jun-Ho Jang ^{[11
]}

Gunnar Juliusson ^{[12
]}

Yasushi Miyazaki ^{[13
]}

Dominik Selleslag ^{[14
]}

Martha L. Arellano ^{[15
]}

Chenglong Liu ^{[16
]}

Jean A. Ridgeway ^{[16
]}

Jalaja Potluri ^{[16
]}

Jovita Schuler ^{[16
]}

Marina Konopleva ^{[6
]}

机构：

[1] City of Hope Comprehensive Cancer Center,Department of Hematology and Hematopoietic Cell Transplantation and Gehr Family Center for Leukemia Research

[2] University of Pennsylvania,Abramson Cancer Center

[3] Ulm University Hospital,Department of Internal Medicine III

[4] Centre Hospitalier Universitaire de Toulouse,Section of Hematology/Oncology, Department of Medicine

[5] The University of Chicago Medicine,Department of Medical Oncology and Hematology

[6] Montefiore-Einstein Comprehensive Cancer Center,Peter MacCallum Cancer Centre, Royal Melbourne Hospital

[7] Hôpital St. Louis/Assistance Publique-Hôpitaux de Paris and Université de Paris,Department of Hematology

[8] Princess Margaret Cancer Centre,Department of Hematology

[9] Walter and Eliza Hall Institute of Medical Research and University of Melbourne,Oncology, Samsung Medical Center

[10] CHU de Bordeaux,Department of Hematology

[11] Sungkyunkwan University School of Medicine,Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute

[12] Skåne University Hospital,Department of Hematology and Medical Oncology, Winship Cancer Institute

[13] Nagasaki University,undefined

[14] Algemeen Ziekenhuis Sint-Jan,undefined

[15] Emory University School of Medicine,undefined

[16] AbbVie Inc.,undefined

来源：

Blood Cancer Journal | / 15卷 / 1期

关键词：

D O I：

10.1038/s41408-025-01263-3

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[31] Allogeneic Hematopoietic Stem Cell Transplantation for Therapy-Related Myelodysplastic Syndromes and Acute Myeloid Leukemia
Metheny, Leland, III
Saber, Wael
Weisdorf, Daniel J.
de Lima, Marcos
Callander, Natalie Scott
Litzow, Mark
Kebriaei, Partow
Hall, Aric C.
Sandmaier, Brenda M.
Zhang, Mei-Jie
Wang, Hai-Lin
Bo-Subait, Khalid
BLOOD, 2019, 134
[32] SAFETY PROFILE OF AZACITIDINE IN THE TREATMENT OF THERAPY-RELATED MYELODYSPLASTIC SYNDROMES/ACUTE MYELOID LEUKAEMIA
Minoia, C.
Sgherza, N.
Greco, G.
Buquicchio, C.
Loseto, G.
de Fazio, V.
Iacobazzi, A.
Rana, A.
Merchionne, F.
Tarantini, G.
Pavone, V.
Guarini, A.
HAEMATOLOGICA, 2014, 99 : 619 - 619
[33] The Impact of PHF6 Mutations in Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, and Acute Myeloid Leukemia
Chien, Kelly S.
Kanagal-Shamanna, Rashmi
Naqvi, Kiran
Sasaki, Koji
Alvarado, Yesid
Takahashi, Koichi
Kadia, Tapan M.
Borthakur, Gautam M.
Jabbour, Elias
Routbort, Mark
Pierce, Sherry A.
Soltysiak, Kelly
Kantarjian, Hagop M.
Garcia-Manero, Guillermo
Montalban-Bravo, Guillermo
BLOOD, 2019, 134
[34] Successful use of Palbociclib combined with Venetoclax and Azacitidine in an adult with refractory/relapsed therapy-related acute myeloid leukemia
Qu, Wenqiang
Lu, Jialing
Ji, Yujie
He, Zhewei
Hou, Mengjia
Li, Dongyang
Yang, Yan
Liu, Dan
Chen, Suning
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2024, 94 (04) : 635 - 639
[35] Health-related quality of life (HRQoL) in patients with untreated higher-risk myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), and chronic myelomonocytic leukemia (CMML) receiving glasdegib plus azacitidine (AZA).
Wang, Eunice S.
Bell, Timothy
Zeidan, Amer Methqal
Bhattacharyya, Helen
Kudla, Art
Chan, Geoffrey
Sekeres, Mikkael A.
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[36] Effect of therapy-related acute myeloid leukemia on the outcome of patients with acute myeloid leukemia
Santo, Ana Espirito
Chacim, Sergio
Ferreira, Isabel
Leite, Luis
Moreira, Claudia
Pereira, Dulcineia
Brito, Margarida Dantas
Nunes, Marta
Domingues, Nelson
Oliveira, Isabel
Moreira, Ilidia
Martins, Angelo
Viterbo, Luisa
Mariz, Jose Mario
Medeiros, Rui
ONCOLOGY LETTERS, 2016, 12 (01) : 262 - 268
[37] Mutational analysis of therapy-related myelodysplastic syndromes and acute myelogenous leukemia
Shih, Alan H.
Chung, Stephen S.
Dolezal, Emily K.
Zhang, Su-Jiang
Abdel-Wahab, Omar I.
Park, Christopher Y.
Nimer, Stephen D.
Levine, Ross L.
Klimek, Virginia M.
HAEMATOLOGICA, 2013, 98 (06) : 908 - 912
[38] Azathioprine: Association with Therapy-related Myelodysplastic Syndrome and Acute Myeloid Leukemia
Kwong, Yok-Lam
JOURNAL OF RHEUMATOLOGY, 2010, 37 (03) : 485 - 490
[39] Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia
Litzow, Mark R.
Tarima, Sergey
Perez, Waleska S.
Bolwell, Brian J.
Cairo, Mitchell S.
Camitta, Bruce M.
Cutler, Corey S.
de Lima, Marcos
DiPersio, John F.
Gale, Robert Peter
Keating, Armand
Lazarus, Hillard M.
Luger, Selina
Marks, David I.
Maziarz, Richard T.
McCarthy, Philip L.
Pasquini, Marcelo C.
Phillips, Gordon L.
Rizzo, J. Douglas
Sierra, Jorge
Tallman, Martin S.
Weisdorf, Daniel J.
BLOOD, 2010, 115 (09) : 1850 - 1857
[40] Venetoclax and azacitidine therapy in acute myeloid leukemia patients with severe renal impairment
Naka, Ryosuke
Kondo, Tadakazu
Nishikubo, Masashi
Muranushi, Hiroyuki
Ueda, Yasunori
Oka, Tomomi
Wada, Fumiya
Kanda, Junya
Yamamoto, Shohei
Watanabe, Mitsumasa
Okada, Shinri
Imada, Kazunori
Nakabo, Yukiharu
Mizutani, Yu
Nannya, Yasuhito
Ogawa, Seishi
Ishikawa, Takayuki
AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (09) : E251 - E254

← 1 2 3 4 5 →